Aspartate transcarbamoylase from Pseudomonadaceae is a class A enzyme consisting of six copies of a 36-kDa catalytic chain and six copies of a 45-kDa polypeptide of unknown function. The 45-kDa polypeptide is homologous to dihydroorotase but lacks catalytic activity. Pseudomonas aeruginosa aspartate transcarbamoylase was overexpressed in Escherichia coli. The homogeneous His-tagged protein isolated in high yield, 30 mg/liter of culture, by affinity chromatography and crystallized. Attempts to dissociate the catalytic and pseudo-dihydroorotase (pDHO) subunits or to express catalytic subunits only were unsuccessful suggesting that the pDHO subunits are required for the proper folding and assembly of the complex. As reported previously, the enzyme was inhibited by micromolar concentrations of all nucleotide triphosphates. In the absence of effectors, the aspartate saturation curves were hyperbolic but became strongly sigmoidal in the presence of low concentrations of nucleotide triphosphates. The inhibition was unusual in that only free ATP, not MgATP, inhibits the enzyme. Moreover, kinetic and binding studies with a fluorescent ATP analog suggested that ATP induces a conformational change that interferes with the binding of carbamoyl phosphate but has little effect once carbamoyl phosphate is bound. The peculiar allosteric properties suggest that the enzyme may be a potential target for novel chemotherapeutic agents designed to combat Pseudomonas infection.Pseudomonadaceae is a family of eubacteria with a wide ecological distribution that is pathogenic in animals (1, 2). Pseudomonas aeruginosa, the principle cause of morbidity and mortality in immunocompromised patients and burn victims (3-5), is an obligate pathogen. In cystic fibrosis, P. aeruginosa infection is the usual cause of death. In the design of therapeutic strategies, comparatively little attention has focused on the physiology of the organism itself, despite the unusual metabolism exhibited by Pseudomonadaceae such as uracil catabolism (6), the lack of gene repression (7,8), and the ability to use arginine as the sole source of carbon, nitrogen, and energy (9, 10).In other organisms, studies of de novo pyrimidine biosynthesis and salvage are actively pursued because of the relationship of these pathways to growth, development, and chemotherapy. Aspartate transcarbamoylase (ATCase, 1 EC 2.1.3.2) catalyzes the formation of carbamoyl aspartate from carbamoyl phosphate and aspartate (11) in the de novo biosynthetic pathway. The structure and function of the enzyme from Escherichia coli has been extensively studied and has become the prototype of allosteric enzymes. However, ATCases are highly polymorphic differing both in structure and mode of regulation. Jones and co-workers (12) identified three distinct classes of bacterial aspartate transcarbamoylase.E. coli ATCase, designated a class B enzyme, consists of six copies of two types of polypeptide chains, catalytic and regulatory. The 34-kDa catalytic chains associate to form catalytically active but unr...